Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
LianBio sees cash runway extending through mid-2024  08:14
05/12/22
05/12
08:14
05/12/22
08:14
LIAN

LianBio

$2.20 /

-0.205 (-8.52%)

 
ShowHide Related Items >><<
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

LIAN LianBio
$2.20 /

-0.205 (-8.52%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

  • 01
    Nov
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

Earnings
LianBio reports Q1 EPS (26c), consensus (30c) » 08:13
05/12/22
05/12
08:13
05/12/22
08:13
LIAN

LianBio

$2.20 /

-0.205 (-8.52%)

Enrollment is ongoing in…

Enrollment is ongoing in the EXPLORER-CN Phase 3 clinical trial of mavacamten in Chinese patients with oHCM. LianBio expects to complete enrollment in the second half of 2022. LianBio remains on track to initiate a Phase 3 clinical trial of TP-03 in Chinese patients with DB in the second half of 2022 to support regulatory approval in China. LianBio expects to begin dosing Chinese patients in Nanobiotix's ongoing global pivotal Phase 3 NANORAY-312 clinical trial of NBTXR3 for the treatment of locally advanced head and neck squamous cell carcinoma in elderly patients ineligible for cisplatin in the second half of 2022. Enrollment is ongoing in LianBio's Phase 2a clinical trial of infigratinib in locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with fibroblast growth factor receptor-2 gene amplification and other advanced solid tumors with FGFR genomic alterations. LianBio expects to begin dosing Chinese patients in QED's ongoing global pivotal Phase 3 PROOF-301 clinical trial of infigratinib in first-line cholangiocarcinoma patients with FGFR2 gene fusions/translocations in the second half of 2022.

ShowHide Related Items >><<
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

LIAN LianBio
$2.20 /

-0.205 (-8.52%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

  • 01
    Nov
LIAN LianBio
$2.20 /

-0.205 (-8.52%)

Hot Stocks
LianBio completes Phase 1 study of Mavacamten in volunteers » 08:21
05/09/22
05/09
08:21
05/09/22
08:21
LIAN

LianBio

$2.45 /

-0.24 (-8.94%)

, BMY

Bristol-Myers

$76.70 /

+0.43 (+0.56%)

LianBio (LIAN) announced…

LianBio (LIAN) announced the completion of a Phase 1 pharmacokinetic study of mavacamten in healthy Chinese volunteers. A single oral administration of mavacamten showed no new safety signals in Chinese healthy adult subjects. The data demonstrated a favorable pharmacokinetic and safety and tolerability profile comparable to that observed in the Phase 1 pharmacokinetic study of mavacamten conducted by its partner, MyoKardia, now a wholly owned subsidiary of Bristol Myers Squibb (BMY), in healthy volunteers in the United States. LianBio licensed rights from MyoKardia, now a wholly owned subsidiary of Bristol Myers Squibb, in August 2020 for the development and commercialization of mavacamten in Mainland China, Hong Kong, Macau, Taiwan, Thailand and Singapore. LianBio is currently conducting EXPLORER-CN, a Phase 3 multicenter, double-blind, randomized, placebo-controlled registrational study designed to evaluate the safety and efficacy of mavacamten in Chinese patients with symptomatic oHCM. Mavacamten was granted Breakthrough Therapy Designation in China for the treatment of patients with oHCM in February 2022. In April 2022, mavacamten was approved by the U.S. Food and Drug Administration under the brand name Camzyos for the treatment of symptomatic New York Heart Association class II-III oHCM to improve functional capacity and symptoms.

ShowHide Related Items >><<
LIAN LianBio
$2.45 /

-0.24 (-8.94%)

BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

LIAN LianBio
$2.45 /

-0.24 (-8.94%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

05/02/22 Truist
Bristol-Myers price target raised to $81 from $76 at Truist
05/02/22 BMO Capital
Bristol-Myers price target raised to $92 from $87 at BMO Capital
05/02/22 Guggenheim
Bristol-Myers price target raised to $80 from $72 at Guggenheim
05/02/22 Barclays
Bristol-Myers price target raised to $68 from $66 at Barclays
LIAN LianBio
$2.45 /

-0.24 (-8.94%)

BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

  • 01
    Nov
BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

LIAN LianBio
$2.45 /

-0.24 (-8.94%)

BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

BMY Bristol-Myers
$76.70 /

+0.43 (+0.56%)

Hot Stocks
LianBio partner Tarsus Pharmaceuticals announces data from trial of TP-03 » 08:10
05/03/22
05/03
08:10
05/03/22
08:10
LIAN

LianBio

$3.71 /

-0.12 (-3.14%)

, TARS

Tarsus Pharmaceuticals

$14.00 /

-4.26 (-23.33%)

LianBio's (LIAN)…

LianBio's (LIAN) partner, Tarsus Pharmaceuticals (TARS), yesterday announced that TP-03 met the primary endpoint and all secondary endpoints in the Saturn-2 pivotal Phase 3 trial with a favorable safety profile, reinforcing its potential to resolve Demodex blepharitis, a highly prevalent eyelid disease. With these results, Tarsus plans to submit a New Drug Application, NDA, to the U.S. Food and Drug Administration, FDA, in the second half of 2022. "We congratulate our partner Tarsus on continuing to demonstrate clinically meaningful and statistically significant disease resolution in the second pivotal trial of TP-03," said Yizhe Wang, Ph.D., chief executive officer of LianBio. "These data reinforce TP-03's potential to become the standard of care for the treatment of Demodex blepharitis. We estimate there are approximately 43 million patients with Demodex blepharitis in China, and there are currently no therapies approved in China for these patients. We look forward to initiating our planned Phase 3 study of TP-03 in China." LianBio licensed rights from Tarsus in March 2021 for the development and commercialization of TP-03 in Greater China. LianBio expects to initiate a registrational Phase 3 clinical trial of TP-03 in the second half of 2022 to support regulatory approval in China.

ShowHide Related Items >><<
TARS Tarsus Pharmaceuticals
$14.00 /

-4.26 (-23.33%)

LIAN LianBio
$3.71 /

-0.12 (-3.14%)

LIAN LianBio
$3.71 /

-0.12 (-3.14%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
TARS Tarsus Pharmaceuticals
$14.00 /

-4.26 (-23.33%)

05/03/22 H.C. Wainwright
Tarsus Pharmaceuticals selloff yesterday unwarranted, says H.C. Wainwright
05/02/22 Oppenheimer
Tarsus Pharmaceuticals price target raised to $66 from $55 at Oppenheimer
12/21/21
Fly Intel: Top five analyst initiations
12/21/21 H.C. Wainwright
Tarsus Pharmaceuticals initiated with a Buy at H.C. Wainwright
LIAN LianBio
$3.71 /

-0.12 (-3.14%)

  • 03
    May
  • 01
    Nov
LIAN LianBio
$3.71 /

-0.12 (-3.14%)

TARS Tarsus Pharmaceuticals
$14.00 /

-4.26 (-23.33%)

On The Fly
What You Missed On Wall Street On Friday » 16:18
04/29/22
04/29
16:18
04/29/22
16:18
BABA

Alibaba

$97.19 /

+6.35 (+6.99%)

, PDD

Pinduoduo

$43.12 /

+5.165 (+13.61%)

, JD

JD.com

$61.71 /

+3.9299 (+6.80%)

, WB

Weibo

$23.15 /

+1.89 (+8.89%)

, AAPL

Apple

$157.86 /

-5.93 (-3.62%)

, AMZN

Amazon.com

$2,485.59 /

-400.92 (-13.89%)

, RIVN

Rivian Automotive

$30.28 /

-1.92 (-5.96%)

, TSLA

Tesla

$870.63 /

-6.38 (-0.73%)

, TWTR

Twitter

$49.01 /

-0.17 (-0.35%)

, INTC

Intel

$43.60 /

-3.37 (-7.17%)

, CVX

Chevron

$156.70 /

-5.2 (-3.21%)

, XOM

Exxon Mobil

$85.21 /

-2.055 (-2.36%)

, ACCD

Accolade

$5.56 /

-5.5 (-49.73%)

, CMCSA

Comcast

$39.77 /

-1.94 (-4.65%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, MA

MasterCard

$363.54 /

-15.08 (-3.98%)

, ROKU

Roku

$92.82 /

+1.32 (+1.44%)

, FBHS

Fortune Brands

$71.26 /

-4.84 (-6.36%)

, NFLX

Netflix

$190.34 /

-9.15 (-4.59%)

, HSBC

HSBC

$31.00 /

+ (+0.00%)

, DB

Deutsche Bank

$9.88 /

-0.35 (-3.42%)

, ZYME

Zymeworks

$6.12 /

+1.15 (+23.14%)

, TAL

TAL Education

$3.39 /

+0.37 (+12.25%)

, OLN

Olin

$57.42 /

+4.13 (+7.75%)

, MHK

Mohawk Industries

$141.00 /

+10.19 (+7.79%)

, AVTR

Avantor

$31.74 /

+1.89 (+6.33%)

, LIAN

LianBio

$3.83 /

-1.195 (-23.80%)

, BMY

Bristol-Myers

$75.33 /

-1.855 (-2.40%)

, WU

Western Union

$16.79 /

-2.37 (-12.37%)

, EGO

Eldorado Gold

$9.72 /

-0.825 (-7.82%)

, HON

Honeywell

$193.58 /

+3.52 (+1.85%)

, ABBV

AbbVie

$146.88 /

-9.515 (-6.08%)

, WIT

Wipro

$6.45 /

-0.355 (-5.22%)

, CG

Carlyle Group

$36.30 /

-2.18 (-5.67%)

, CLW

Clearwater Paper

$33.11 /

+5.35 (+19.27%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYME Zymeworks
$6.12 /

+1.15 (+23.14%)

XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

WU Western Union
$16.79 /

-2.37 (-12.37%)

WIT Wipro
$6.45 /

-0.355 (-5.22%)

WB Weibo
$23.15 /

+1.89 (+8.89%)

TWTR Twitter
$49.01 /

-0.17 (-0.35%)

TSLA Tesla
$870.63 /

-6.38 (-0.73%)

TAL TAL Education
$3.39 /

+0.37 (+12.25%)

ROKU Roku
$92.82 /

+1.32 (+1.44%)

RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

PDD Pinduoduo
$43.12 /

+5.165 (+13.61%)

OLN Olin
$57.42 /

+4.13 (+7.75%)

NFLX Netflix
$190.34 /

-9.15 (-4.59%)

MHK Mohawk Industries
$141.00 /

+10.19 (+7.79%)

MA MasterCard
$363.54 /

-15.08 (-3.98%)

LIAN LianBio
$3.83 /

-1.195 (-23.80%)

JD JD.com
$61.71 /

+3.9299 (+6.80%)

INTC Intel
$43.60 /

-3.37 (-7.17%)

HSBC HSBC
$31.00 /

+ (+0.00%)

HON Honeywell
$193.58 /

+3.52 (+1.85%)

FBHS Fortune Brands
$71.26 /

-4.84 (-6.36%)

EGO Eldorado Gold
$9.72 /

-0.825 (-7.82%)

DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

CVX Chevron
$156.70 /

-5.2 (-3.21%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

CLW Clearwater Paper
$33.11 /

+5.35 (+19.27%)

CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

AVTR Avantor
$31.74 /

+1.89 (+6.33%)

AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

ACCD Accolade
$5.56 /

-5.5 (-49.73%)

ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

AAPL Apple
$157.86 /

-5.93 (-3.62%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

04/11/22 UBS
Alibaba price target lowered to $140 from $150 at UBS
04/10/22 Goldman Sachs
Alibaba assumed with a Buy at Goldman Sachs
04/08/22 HSBC
Alibaba price target lowered to $156 from $168 at HSBC
04/07/22 Benchmark
Alibaba price target lowered to $220 from $235 at Benchmark
PDD Pinduoduo
$43.12 /

+5.165 (+13.61%)

04/29/22 86 Research
Pinduoduo upgraded to Buy from Hold at 86 Research
04/10/22 Goldman Sachs
Pinduoduo assumed with a Buy at Goldman Sachs
03/23/22 UBS
UBS upgrades Pinduoduo to Buy on gross margin expansion offsetting slower growth
03/23/22 UBS
Pinduoduo upgraded to Buy from Neutral at UBS
JD JD.com
$61.71 /

+3.9299 (+6.80%)

04/13/22 CLSA
JD.com price target lowered to $100 from $108 at CLSA
03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
03/14/22 JPMorgan
JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
03/14/22 JPMorgan
JD.com downgraded to Underweight from Overweight at JPMorgan
WB Weibo
$23.15 /

+1.89 (+8.89%)

04/10/22 Goldman Sachs
Weibo assumed with a Neutral at Goldman Sachs
03/14/22 JPMorgan
Weibo price target lowered to $24 from $32 at JPMorgan
03/11/22 UBS
Weibo downgraded to Neutral at UBS on weaker ad growth and margin outlook
03/11/22 UBS
Weibo downgraded to Neutral from Buy at UBS
AAPL Apple
$157.86 /

-5.93 (-3.62%)

04/29/22 Evercore ISI
Apple still well positioned for low double digit EPS growth, says Evercore ISI
04/29/22 Wells Fargo
Apple's Q2 results 'solid' amid worsening supply chain impacts, says Wells Fargo
04/29/22 Baird
Apple weakness would be a buying opportunity, says Baird
04/29/22 Deutsche Bank
Apple price target lowered to $200 from $210 at Deutsche Bank
AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

04/29/22 Truist
Amazon.com price target lowered to $3,500 from $4,000 at Truist
04/29/22 Evercore ISI
Amazon price target lowered to $4,100 from $4,300 at Evercore ISI
04/29/22 DA Davidson
Amazon.com price target lowered to $3,125 from $3,900 at DA Davidson
04/29/22 BMO Capital
Amazon.com price target lowered to $3,450 from $3,650 at BMO Capital
RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

04/26/22 Barclays
Rivian Automotive price target lowered to $38 from $42 at Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
04/21/22 Deutsche Bank
Rivian Automotive price target lowered to $90 from $91 at Deutsche Bank
04/20/22 Mizuho
Rivian Automotive price target lowered to $90 from $95 at Mizuho
TSLA Tesla
$870.63 /

-6.38 (-0.73%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
TWTR Twitter
$49.01 /

-0.17 (-0.35%)

04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
04/26/22 Wedbush
Twitter price target raised to $54 from $42 at Wedbush
INTC Intel
$43.60 /

-3.37 (-7.17%)

04/29/22 Northland
Intel Q2 guidance looks conservative, says Northland
04/27/22 Lynx
Lynx sees China supply risks extending into Q3
04/14/22 Credit Suisse
TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
04/12/22 Citi
Citi sees 'another yellow flag' for Intel, reiterates Neutral
CVX Chevron
$156.70 /

-5.2 (-3.21%)

04/21/22 Truist
Chevron price target raised to $186 from $160 at Truist
04/21/22 RBC Capital
Chevron downgraded to Sector Perform from Outperform at RBC Capital
04/05/22 UBS
Chevron price target raised to $192 from $150 at UBS
03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

04/21/22 Truist
Exxon Mobil price target raised to $84 from $75 at Truist
04/21/22 RBC Capital
Exxon Mobil upgraded to Outperform from Sector Perform at RBC Capital
ACCD Accolade
$5.56 /

-5.5 (-49.73%)

04/29/22 SVB Leerink
Accolade downgraded to Market Perform from Outperform at SVB Leerink
04/29/22 Stifel
Accolade removed from 'Select List,' price target lowered to $16 at Stifel
04/29/22 Canaccord
Accolade price target lowered to $17 from $34 at Canaccord
04/29/22 Needham
Accolade price target lowered to $12 from $33 at Needham
CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

04/29/22 Morgan Stanley
Comcast price target lowered to $55 from $60 at Morgan Stanley
04/29/22 Deutsche Bank
Comcast price target lowered to $60 from $62 at Deutsche Bank
04/29/22 BTIG
Accolade downgraded to Neutral from Buy at BTIG
CMCSK Comcast
$58.00 /

+ (+0.00%)

04/14/22 Oppenheimer
Comcast price target lowered to $60 from $75 at Oppenheimer
03/23/22 Craig-Hallum
ComScore poised for share gains in local measurement, says Craig-Hallum
MA MasterCard
$363.54 /

-15.08 (-3.98%)

04/29/22 BMO Capital
MasterCard price target lowered to $402 from $412 at BMO Capital
04/29/22 Deutsche Bank
MasterCard price target raised to $440 from $420 at Deutsche Bank
04/29/22 Citi
MasterCard price target raised to $453 from $435 at Citi
04/29/22 JPMorgan
MasterCard price target raised to $430 from $400 at JPMorgan
ROKU Roku
$92.82 /

+1.32 (+1.44%)

04/29/22 Benchmark
Benchmark 'incrementally more confident' in improving Roku growth after Q1
04/29/22 DA Davidson
Roku price target lowered to $170 from $200 at DA Davidson
04/29/22 Stephens
Roku price target lowered to $190 from $230 at Stephens
04/29/22 Oppenheimer
Roku price target lowered to $155 from $185 at Oppenheimer
FBHS Fortune Brands
$71.26 /

-4.84 (-6.36%)

04/29/22 Truist
Fortune Brands price target lowered to $100 from $115 at Truist
04/29/22 BofA
Fortune Brands upgraded to Neutral at BofA on cabinets spinoff plan
04/29/22 BofA
Fortune Brands upgraded to Neutral from Underperform at BofA
04/29/22 KeyBanc
Fortune Brands downgraded to Sector Weight from Overweight at KeyBanc
NFLX Netflix
$190.34 /

-9.15 (-4.59%)

04/21/22 Benchmark
Roku price target lowered to $240 from $305 at Benchmark
04/21/22 Citi
Netflix price target lowered to $295 from $450 at Citi
04/21/22 Edward Jones
Netflix downgraded to Hold from Buy at Edward Jones
04/21/22 DZ Bank
Netflix downgraded to Hold from Buy at DZ Bank
HSBC HSBC
$31.00 /

+ (+0.00%)

04/27/22 Credit Suisse
HSBC price target lowered to 515 GBp from 530 GBp at Credit Suisse
04/20/22 Barclays
HSBC price target raised to 735 GBp from 725 GBp at Barclays
03/14/22 JPMorgan
HSBC price target lowered to 510 GBp from 570 GBp at JPMorgan
03/04/22 RBC Capital
HSBC price target raised to 570 GBp from 530 GBp at RBC Capital
DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

04/29/22 UBS
Deutsche Bank price target raised to EUR 16.30 from EUR 15.30 at UBS
04/28/22 RBC Capital
Deutsche Bank price target raised to EUR 13 from EUR 12.50 at RBC Capital
04/21/22 Morgan Stanley
Deutsche Bank price target lowered to EUR 14.90 at Morgan Stanley
04/04/22 JPMorgan
Deutsche Bank price target raised to EUR 15 from EUR 14 at JPMorgan
ZYME Zymeworks
$6.12 /

+1.15 (+23.14%)

03/15/22 Evercore ISI
Zymeworks initiated with an Outperform at Evercore ISI
02/28/22 Piper Sandler
Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
02/28/22 Citi
Zymeworks price target lowered to $30 from $53 at Citi
02/09/22 Wells Fargo
Zymeworks price target lowered to $45 from $56 at Wells Fargo
TAL TAL Education
$3.39 /

+0.37 (+12.25%)

03/09/22 Daiwa
TAL Education upgraded to Buy from Neutral at Daiwa
03/07/22 Morgan Stanley
Youdao upgraded to Overweight from Equal Weight at Morgan Stanley
03/07/22 Morgan Stanley
TAL Education upgraded to Overweight from Underweight at Morgan Stanley
OLN Olin
$57.42 /

+4.13 (+7.75%)

04/14/22 JPMorgan
Olin added to Analyst Focus List at JPMorgan
03/14/22 KeyBanc
KeyBanc upgrades Olin to Overweight with $64 price target
03/14/22 KeyBanc
Olin upgraded to Overweight from Sector Weight at KeyBanc
01/31/22 Fermium Research
Olin price target raised to $70 from $60 at Fermium Research
MHK Mohawk Industries
$141.00 /

+10.19 (+7.79%)

04/21/22 Wells Fargo
Mohawk Industries price target lowered to $135 from $155 at Wells Fargo
04/20/22 JPMorgan
Mohawk Industries price target lowered to $127 from $140 at JPMorgan
04/12/22 Loop Capital
Mohawk Industries price target lowered to $130 from $165 at Loop Capital
04/05/22 Credit Suisse
Mohawk Industries initiated with a Neutral at Credit Suisse
AVTR Avantor
$31.74 /

+1.89 (+6.33%)

04/19/22 Cowen
Avantor price target lowered to $44 from $50 at Cowen
04/18/22 Evercore ISI
Avantor added to 'TAP Outperform' list at Evercore ISI
04/04/22 Evercore ISI
Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
04/04/22 Citi
Avantor downgraded to Neutral on 'number of headwinds' at Citi
LIAN LianBio
$3.83 /

-1.195 (-23.80%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

04/18/22 Goldman Sachs
Nektar downgraded to Sell from Neutral at Goldman Sachs
04/18/22 Mizuho
Nektar price target lowered to $6 from $8 at Mizuho
04/06/22 Morgan Stanley
Bristol-Myers assumed with an Underweight at Morgan Stanley
03/30/22 BMO Capital
Bristol-Myers price target raised to $81 from $74 at BMO Capital
WU Western Union
$16.79 /

-2.37 (-12.37%)

04/29/22 Citi
Citi downgrades Western Union to Neutral, sees shares being range-bound
04/29/22 Citi
Western Union downgraded to Neutral from Buy at Citi
04/29/22 JPMorgan
Western Union price target lowered to $19 from $20 at JPMorgan
03/31/22 UBS
Western Union initiated with a Neutral at UBS
EGO Eldorado Gold
$9.72 /

-0.825 (-7.82%)

04/20/22 National Bank
Eldorado Gold price target raised to C$20 from C$18 at National Bank
02/08/22 Stifel
Eldorado Gold price target lowered to C$20.25 from C$21.50 at Stifel
02/04/22 National Bank
Eldorado Gold price target raised to C$17 from C$16 at National Bank
01/19/22 National Bank
Eldorado Gold price target lowered to C$16 from C$17.50 at National Bank
HON Honeywell
$193.58 /

+3.52 (+1.85%)

04/14/22 Deutsche Bank
Honeywell price target lowered to $230 from $243 at Deutsche Bank
04/14/22 Deutsche Bank
Honeywell named short-term buy idea at Deutsche Bank
03/28/22 Cowen
Honeywell first half consensus may be too high, says Cowen
03/04/22 Deutsche Bank
Honeywell price target raised to $243 from $237 at Deutsche Bank
ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

04/29/22 Piper Sandler
Piper says buy AbbVie 'right here' despite 'disappointing' Q1
04/29/22 Piper Sandler
AbbVie data miss removes primary Vertex overhang, says Piper Sandler
04/25/22 BMO Capital
AbbVie price target raised to $174 from $161 at BMO Capital
04/22/22 Piper Sandler
Biohaven widening lead over AbbVie in migraine, says Piper Sandler
WIT Wipro
$6.45 /

-0.355 (-5.22%)

04/11/22 Macquarie
Wipro initiated with a Neutral at Macquarie
02/21/22 CLSA
Wipro upgraded to Outperform from Underperform at CLSA
02/04/22 Jefferies
Wipro upgraded to Hold yesterday at Jefferies following 20% correction
02/03/22 Jefferies
Wipro upgraded to Hold from Underperform at Jefferies
CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

04/29/22 BMO Capital
Carlyle Group price target lowered to $60 from $69 at BMO Capital
04/22/22 BMO Capital
Blackstone price target raised to $142 from $124 at BMO Capital
04/13/22 Oppenheimer
Carlyle Group price target raised to $80 from $71 at Oppenheimer
04/13/22 Oppenheimer
Oppenheimer upgrades Apollo Global following 23% year-to-date pullback
CLW Clearwater Paper
$33.11 /

+5.35 (+19.27%)

02/16/22 BMO Capital
Clearwater Paper upgraded to Outperform at BMO amid 'overdone' move lower
02/16/22 BMO Capital
Clearwater Paper upgraded to Outperform from Market Perform at BMO Capital
02/16/22 RBC Capital
Clearwater Paper cut to Sector Perform at RBC Capital on likely lower cash flow
02/16/22 RBC Capital
Clearwater Paper downgraded to Sector Perform from Outperform at RBC Capital
ZYME Zymeworks
$6.12 /

+1.15 (+23.14%)

XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

WU Western Union
$16.79 /

-2.37 (-12.37%)

WIT Wipro
$6.45 /

-0.355 (-5.22%)

WB Weibo
$23.15 /

+1.89 (+8.89%)

TWTR Twitter
$49.01 /

-0.17 (-0.35%)

TSLA Tesla
$870.63 /

-6.38 (-0.73%)

TAL TAL Education
$3.39 /

+0.37 (+12.25%)

ROKU Roku
$92.82 /

+1.32 (+1.44%)

RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

PDD Pinduoduo
$43.12 /

+5.165 (+13.61%)

OLN Olin
$57.42 /

+4.13 (+7.75%)

NFLX Netflix
$190.34 /

-9.15 (-4.59%)

MHK Mohawk Industries
$141.00 /

+10.19 (+7.79%)

MA MasterCard
$363.54 /

-15.08 (-3.98%)

LIAN LianBio
$3.83 /

-1.195 (-23.80%)

JD JD.com
$61.71 /

+3.9299 (+6.80%)

INTC Intel
$43.60 /

-3.37 (-7.17%)

HSBC HSBC
$31.00 /

+ (+0.00%)

HON Honeywell
$193.58 /

+3.52 (+1.85%)

FBHS Fortune Brands
$71.26 /

-4.84 (-6.36%)

EGO Eldorado Gold
$9.72 /

-0.825 (-7.82%)

DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

CVX Chevron
$156.70 /

-5.2 (-3.21%)

CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

CLW Clearwater Paper
$33.11 /

+5.35 (+19.27%)

CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

AVTR Avantor
$31.74 /

+1.89 (+6.33%)

AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

ACCD Accolade
$5.56 /

-5.5 (-49.73%)

ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

AAPL Apple
$157.86 /

-5.93 (-3.62%)

  • 27
    Jan
  • 02
    Dec
  • 10
    Nov
  • 10
    Nov
  • 01
    Nov
  • 14
    Sep
  • 19
    May
XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

WB Weibo
$23.15 /

+1.89 (+8.89%)

TWTR Twitter
$49.01 /

-0.17 (-0.35%)

TSLA Tesla
$870.63 /

-6.38 (-0.73%)

ROKU Roku
$92.82 /

+1.32 (+1.44%)

RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

PDD Pinduoduo
$43.12 /

+5.165 (+13.61%)

NFLX Netflix
$190.34 /

-9.15 (-4.59%)

MA MasterCard
$363.54 /

-15.08 (-3.98%)

INTC Intel
$43.60 /

-3.37 (-7.17%)

HSBC HSBC
$31.00 /

+ (+0.00%)

DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

CVX Chevron
$156.70 /

-5.2 (-3.21%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

AAPL Apple
$157.86 /

-5.93 (-3.62%)

XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

WU Western Union
$16.79 /

-2.37 (-12.37%)

WIT Wipro
$6.45 /

-0.355 (-5.22%)

WB Weibo
$23.15 /

+1.89 (+8.89%)

TWTR Twitter
$49.01 /

-0.17 (-0.35%)

TSLA Tesla
$870.63 /

-6.38 (-0.73%)

TAL TAL Education
$3.39 /

+0.37 (+12.25%)

ROKU Roku
$92.82 /

+1.32 (+1.44%)

RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

OLN Olin
$57.42 /

+4.13 (+7.75%)

NFLX Netflix
$190.34 /

-9.15 (-4.59%)

MHK Mohawk Industries
$141.00 /

+10.19 (+7.79%)

LIAN LianBio
$3.83 /

-1.195 (-23.80%)

INTC Intel
$43.60 /

-3.37 (-7.17%)

HON Honeywell
$193.58 /

+3.52 (+1.85%)

DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

CVX Chevron
$156.70 /

-5.2 (-3.21%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

CLW Clearwater Paper
$33.11 /

+5.35 (+19.27%)

CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

ACCD Accolade
$5.56 /

-5.5 (-49.73%)

ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

AAPL Apple
$157.86 /

-5.93 (-3.62%)

XOM Exxon Mobil
$85.21 /

-2.055 (-2.36%)

WU Western Union
$16.79 /

-2.37 (-12.37%)

WB Weibo
$23.15 /

+1.89 (+8.89%)

TWTR Twitter
$49.01 /

-0.17 (-0.35%)

TSLA Tesla
$870.63 /

-6.38 (-0.73%)

TAL TAL Education
$3.39 /

+0.37 (+12.25%)

ROKU Roku
$92.82 /

+1.32 (+1.44%)

RIVN Rivian Automotive
$30.28 /

-1.92 (-5.96%)

PDD Pinduoduo
$43.12 /

+5.165 (+13.61%)

OLN Olin
$57.42 /

+4.13 (+7.75%)

NFLX Netflix
$190.34 /

-9.15 (-4.59%)

MHK Mohawk Industries
$141.00 /

+10.19 (+7.79%)

MA MasterCard
$363.54 /

-15.08 (-3.98%)

JD JD.com
$61.71 /

+3.9299 (+6.80%)

INTC Intel
$43.60 /

-3.37 (-7.17%)

HSBC HSBC
$31.00 /

+ (+0.00%)

HON Honeywell
$193.58 /

+3.52 (+1.85%)

DB Deutsche Bank
$9.88 /

-0.35 (-3.42%)

CVX Chevron
$156.70 /

-5.2 (-3.21%)

CMCSA Comcast
$39.77 /

-1.94 (-4.65%)

CG Carlyle Group
$36.30 /

-2.18 (-5.67%)

BMY Bristol-Myers
$75.33 /

-1.855 (-2.40%)

BABA Alibaba
$97.19 /

+6.35 (+6.99%)

AMZN Amazon.com
$2,485.59 /

-400.92 (-13.89%)

ACCD Accolade
$5.56 /

-5.5 (-49.73%)

ABBV AbbVie
$146.88 /

-9.515 (-6.08%)

AAPL Apple
$157.86 /

-5.93 (-3.62%)

On The Fly
What You Missed On Wall Street This Morning » 12:37
04/29/22
04/29
12:37
04/29/22
12:37
AAPL

Apple

$160.53 /

-3.26 (-1.99%)

, AMZN

Amazon.com

$2,520.02 /

-366.49 (-12.70%)

, TSLA

Tesla

$905.80 /

+28.79 (+3.28%)

, TWTR

Twitter

$49.55 /

+0.37 (+0.75%)

, INTC

Intel

$44.13 /

-2.845 (-6.06%)

, CVX

Chevron

$158.10 /

-3.8 (-2.35%)

, BABA

Alibaba

$100.62 /

+9.78 (+10.77%)

, PDD

Pinduoduo

$44.40 /

+6.45 (+17.00%)

, JD

JD.com

$62.81 /

+5.03 (+8.71%)

, WB

Weibo

$23.63 /

+2.375 (+11.17%)

, HSBC

HSBC

$31.30 /

+0.3 (+0.97%)

, NFLX

Netflix

$197.76 /

-1.73 (-0.87%)

, HNHPF

Hon Hai Precision

$6.84 /

+0.175 (+2.63%)

, ZYME

Zymeworks

$6.67 /

+1.7 (+34.21%)

, TAL

TAL Education

$3.40 /

+0.38 (+12.58%)

, OLN

Olin

$57.93 /

+4.64 (+8.71%)

, MHK

Mohawk Industries

$142.67 /

+11.86 (+9.07%)

, AVTR

Avantor

$32.32 /

+2.47 (+8.27%)

, LIAN

LianBio

$3.90 /

-1.12 (-22.31%)

, ACCD

Accolade

$5.96 /

-5.1 (-46.11%)

, WU

Western Union

$17.04 /

-2.12 (-11.06%)

, EGO

Eldorado Gold

$9.70 /

-0.845 (-8.01%)

, HON

Honeywell

$194.93 /

+4.87 (+2.56%)

, ABBV

AbbVie

$142.37 /

-14.02 (-8.96%)

, WIT

Wipro

$6.50 /

-0.305 (-4.48%)

, CG

Carlyle Group

$37.74 /

-0.74 (-1.92%)

, CLW

Clearwater Paper

$33.84 /

+6.08 (+21.90%)

, MA

MasterCard

$368.80 /

-9.82 (-2.59%)

, CMCSA

Comcast

$40.02 /

-1.695 (-4.06%)

, RIVN

Rivian Automotive

$31.75 /

-0.45 (-1.40%)

, ROKU

Roku

$98.10 /

+6.6 (+7.21%)

, FBHS

Fortune Brands

$73.69 /

-2.41 (-3.17%)

, BMY

Bristol-Myers

$74.80 /

-2.385 (-3.09%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYME Zymeworks
$6.67 /

+1.7 (+34.21%)

WU Western Union
$17.04 /

-2.12 (-11.06%)

WIT Wipro
$6.50 /

-0.305 (-4.48%)

WB Weibo
$23.63 /

+2.375 (+11.17%)

TWTR Twitter
$49.55 /

+0.37 (+0.75%)

TSLA Tesla
$905.80 /

+28.79 (+3.28%)

TAL TAL Education
$3.40 /

+0.38 (+12.58%)

ROKU Roku
$98.10 /

+6.6 (+7.21%)

RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

OLN Olin
$57.93 /

+4.64 (+8.71%)

NFLX Netflix
$197.76 /

-1.73 (-0.87%)

MHK Mohawk Industries
$142.67 /

+11.86 (+9.07%)

MA MasterCard
$368.80 /

-9.82 (-2.59%)

LIAN LianBio
$3.90 /

-1.12 (-22.31%)

JD JD.com
$62.81 /

+5.03 (+8.71%)

INTC Intel
$44.13 /

-2.845 (-6.06%)

HSBC HSBC
$31.30 /

+0.3 (+0.97%)

HON Honeywell
$194.93 /

+4.87 (+2.56%)

HNHPF Hon Hai Precision
$6.84 /

+0.175 (+2.63%)

FBHS Fortune Brands
$73.69 /

-2.41 (-3.17%)

EGO Eldorado Gold
$9.70 /

-0.845 (-8.01%)

CVX Chevron
$158.10 /

-3.8 (-2.35%)

CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

CLW Clearwater Paper
$33.84 /

+6.08 (+21.90%)

CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

BABA Alibaba
$100.62 /

+9.78 (+10.77%)

AVTR Avantor
$32.32 /

+2.47 (+8.27%)

AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

ACCD Accolade
$5.96 /

-5.1 (-46.11%)

ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

04/29/22 Evercore ISI
Apple still well positioned for low double digit EPS growth, says Evercore ISI
04/29/22 Wells Fargo
Apple's Q2 results 'solid' amid worsening supply chain impacts, says Wells Fargo
04/29/22 Baird
Apple weakness would be a buying opportunity, says Baird
04/29/22 Deutsche Bank
Apple price target lowered to $200 from $210 at Deutsche Bank
AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

04/29/22 Truist
Amazon.com price target lowered to $3,500 from $4,000 at Truist
04/29/22 Evercore ISI
Amazon price target lowered to $4,100 from $4,300 at Evercore ISI
04/29/22 DA Davidson
Amazon.com price target lowered to $3,125 from $3,900 at DA Davidson
04/29/22 BMO Capital
Amazon.com price target lowered to $3,450 from $3,650 at BMO Capital
TSLA Tesla
$905.80 /

+28.79 (+3.28%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
TWTR Twitter
$49.55 /

+0.37 (+0.75%)

04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
04/26/22 Wedbush
Twitter price target raised to $54 from $42 at Wedbush
INTC Intel
$44.13 /

-2.845 (-6.06%)

04/29/22 Northland
Intel Q2 guidance looks conservative, says Northland
04/27/22 Lynx
Lynx sees China supply risks extending into Q3
04/14/22 Credit Suisse
TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
04/12/22 Citi
Citi sees 'another yellow flag' for Intel, reiterates Neutral
CVX Chevron
$158.10 /

-3.8 (-2.35%)

04/21/22 Truist
Chevron price target raised to $186 from $160 at Truist
04/21/22 RBC Capital
Chevron downgraded to Sector Perform from Outperform at RBC Capital
04/05/22 UBS
Chevron price target raised to $192 from $150 at UBS
03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
BABA Alibaba
$100.62 /

+9.78 (+10.77%)

04/11/22 UBS
Alibaba price target lowered to $140 from $150 at UBS
04/10/22 Goldman Sachs
Alibaba assumed with a Buy at Goldman Sachs
04/08/22 HSBC
Alibaba price target lowered to $156 from $168 at HSBC
04/07/22 Benchmark
Alibaba price target lowered to $220 from $235 at Benchmark
PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

04/29/22 86 Research
Pinduoduo upgraded to Buy from Hold at 86 Research
04/10/22 Goldman Sachs
Pinduoduo assumed with a Buy at Goldman Sachs
03/23/22 UBS
UBS upgrades Pinduoduo to Buy on gross margin expansion offsetting slower growth
03/23/22 UBS
Pinduoduo upgraded to Buy from Neutral at UBS
JD JD.com
$62.81 /

+5.03 (+8.71%)

04/13/22 CLSA
JD.com price target lowered to $100 from $108 at CLSA
03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
03/14/22 JPMorgan
JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
03/14/22 JPMorgan
JD.com downgraded to Underweight from Overweight at JPMorgan
WB Weibo
$23.63 /

+2.375 (+11.17%)

04/10/22 Goldman Sachs
Weibo assumed with a Neutral at Goldman Sachs
03/14/22 JPMorgan
Weibo price target lowered to $24 from $32 at JPMorgan
03/11/22 UBS
Weibo downgraded to Neutral at UBS on weaker ad growth and margin outlook
03/11/22 UBS
Weibo downgraded to Neutral from Buy at UBS
HSBC HSBC
$31.30 /

+0.3 (+0.97%)

04/27/22 Credit Suisse
HSBC price target lowered to 515 GBp from 530 GBp at Credit Suisse
04/20/22 Barclays
HSBC price target raised to 735 GBp from 725 GBp at Barclays
03/14/22 JPMorgan
HSBC price target lowered to 510 GBp from 570 GBp at JPMorgan
03/04/22 RBC Capital
HSBC price target raised to 570 GBp from 530 GBp at RBC Capital
NFLX Netflix
$197.76 /

-1.73 (-0.87%)

04/21/22 Benchmark
Roku price target lowered to $240 from $305 at Benchmark
04/21/22 Citi
Netflix price target lowered to $295 from $450 at Citi
04/21/22 Edward Jones
Netflix downgraded to Hold from Buy at Edward Jones
04/21/22 DZ Bank
Netflix downgraded to Hold from Buy at DZ Bank
HNHPF Hon Hai Precision
$6.84 /

+0.175 (+2.63%)

03/14/22 BofA
Apple exposure to Shenzhen and Suzhou 'manageable,' says BofA
11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
ZYME Zymeworks
$6.67 /

+1.7 (+34.21%)

03/15/22 Evercore ISI
Zymeworks initiated with an Outperform at Evercore ISI
02/28/22 Piper Sandler
Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
02/28/22 Citi
Zymeworks price target lowered to $30 from $53 at Citi
02/09/22 Wells Fargo
Zymeworks price target lowered to $45 from $56 at Wells Fargo
TAL TAL Education
$3.40 /

+0.38 (+12.58%)

03/09/22 Daiwa
TAL Education upgraded to Buy from Neutral at Daiwa
03/07/22 Morgan Stanley
Youdao upgraded to Overweight from Equal Weight at Morgan Stanley
03/07/22 Morgan Stanley
TAL Education upgraded to Overweight from Underweight at Morgan Stanley
OLN Olin
$57.93 /

+4.64 (+8.71%)

04/14/22 JPMorgan
Olin added to Analyst Focus List at JPMorgan
03/14/22 KeyBanc
KeyBanc upgrades Olin to Overweight with $64 price target
03/14/22 KeyBanc
Olin upgraded to Overweight from Sector Weight at KeyBanc
01/31/22 Fermium Research
Olin price target raised to $70 from $60 at Fermium Research
MHK Mohawk Industries
$142.67 /

+11.86 (+9.07%)

04/21/22 Wells Fargo
Mohawk Industries price target lowered to $135 from $155 at Wells Fargo
04/20/22 JPMorgan
Mohawk Industries price target lowered to $127 from $140 at JPMorgan
04/12/22 Loop Capital
Mohawk Industries price target lowered to $130 from $165 at Loop Capital
04/05/22 Credit Suisse
Mohawk Industries initiated with a Neutral at Credit Suisse
AVTR Avantor
$32.32 /

+2.47 (+8.27%)

04/19/22 Cowen
Avantor price target lowered to $44 from $50 at Cowen
04/18/22 Evercore ISI
Avantor added to 'TAP Outperform' list at Evercore ISI
04/04/22 Evercore ISI
Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
04/04/22 Citi
Avantor downgraded to Neutral on 'number of headwinds' at Citi
LIAN LianBio
$3.90 /

-1.12 (-22.31%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
ACCD Accolade
$5.96 /

-5.1 (-46.11%)

04/29/22 SVB Leerink
Accolade downgraded to Market Perform from Outperform at SVB Leerink
04/29/22 Stifel
Accolade removed from 'Select List,' price target lowered to $16 at Stifel
04/29/22 Canaccord
Accolade price target lowered to $17 from $34 at Canaccord
04/29/22 Needham
Accolade price target lowered to $12 from $33 at Needham
WU Western Union
$17.04 /

-2.12 (-11.06%)

04/29/22 Citi
Citi downgrades Western Union to Neutral, sees shares being range-bound
04/29/22 Citi
Western Union downgraded to Neutral from Buy at Citi
04/29/22 JPMorgan
Western Union price target lowered to $19 from $20 at JPMorgan
03/31/22 UBS
Western Union initiated with a Neutral at UBS
EGO Eldorado Gold
$9.70 /

-0.845 (-8.01%)

04/20/22 National Bank
Eldorado Gold price target raised to C$20 from C$18 at National Bank
02/08/22 Stifel
Eldorado Gold price target lowered to C$20.25 from C$21.50 at Stifel
02/04/22 National Bank
Eldorado Gold price target raised to C$17 from C$16 at National Bank
01/19/22 National Bank
Eldorado Gold price target lowered to C$16 from C$17.50 at National Bank
HON Honeywell
$194.93 /

+4.87 (+2.56%)

04/14/22 Deutsche Bank
Honeywell price target lowered to $230 from $243 at Deutsche Bank
04/14/22 Deutsche Bank
Honeywell named short-term buy idea at Deutsche Bank
03/28/22 Cowen
Honeywell first half consensus may be too high, says Cowen
03/04/22 Deutsche Bank
Honeywell price target raised to $243 from $237 at Deutsche Bank
ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

04/29/22 Piper Sandler
AbbVie data miss removes primary Vertex overhang, says Piper Sandler
04/25/22 BMO Capital
AbbVie price target raised to $174 from $161 at BMO Capital
04/22/22 Piper Sandler
Biohaven widening lead over AbbVie in migraine, says Piper Sandler
04/14/22 JPMorgan
Royalty Pharma upgraded to Overweight on valuation at JPMorgan
WIT Wipro
$6.50 /

-0.305 (-4.48%)

04/11/22 Macquarie
Wipro initiated with a Neutral at Macquarie
02/21/22 CLSA
Wipro upgraded to Outperform from Underperform at CLSA
02/04/22 Jefferies
Wipro upgraded to Hold yesterday at Jefferies following 20% correction
02/03/22 Jefferies
Wipro upgraded to Hold from Underperform at Jefferies
CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

04/29/22 BMO Capital
Carlyle Group price target lowered to $60 from $69 at BMO Capital
04/22/22 BMO Capital
Blackstone price target raised to $142 from $124 at BMO Capital
04/13/22 Oppenheimer
Carlyle Group price target raised to $80 from $71 at Oppenheimer
04/13/22 Oppenheimer
Oppenheimer upgrades Apollo Global following 23% year-to-date pullback
CLW Clearwater Paper
$33.84 /

+6.08 (+21.90%)

02/16/22 BMO Capital
Clearwater Paper upgraded to Outperform at BMO amid 'overdone' move lower
02/16/22 BMO Capital
Clearwater Paper upgraded to Outperform from Market Perform at BMO Capital
02/16/22 RBC Capital
Clearwater Paper cut to Sector Perform at RBC Capital on likely lower cash flow
02/16/22 RBC Capital
Clearwater Paper downgraded to Sector Perform from Outperform at RBC Capital
MA MasterCard
$368.80 /

-9.82 (-2.59%)

04/29/22 BMO Capital
MasterCard price target lowered to $402 from $412 at BMO Capital
04/29/22 Deutsche Bank
MasterCard price target raised to $440 from $420 at Deutsche Bank
04/29/22 Citi
MasterCard price target raised to $453 from $435 at Citi
04/29/22 JPMorgan
MasterCard price target raised to $430 from $400 at JPMorgan
CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

04/29/22 Morgan Stanley
Comcast price target lowered to $55 from $60 at Morgan Stanley
04/29/22 Deutsche Bank
Comcast price target lowered to $60 from $62 at Deutsche Bank
04/29/22 BTIG
Accolade downgraded to Neutral from Buy at BTIG
RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

04/26/22 Barclays
Rivian Automotive price target lowered to $38 from $42 at Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
04/21/22 Deutsche Bank
Rivian Automotive price target lowered to $90 from $91 at Deutsche Bank
04/20/22 Mizuho
Rivian Automotive price target lowered to $90 from $95 at Mizuho
ROKU Roku
$98.10 /

+6.6 (+7.21%)

04/29/22 Benchmark
Benchmark 'incrementally more confident' in improving Roku growth after Q1
04/29/22 DA Davidson
Roku price target lowered to $170 from $200 at DA Davidson
04/29/22 Stephens
Roku price target lowered to $190 from $230 at Stephens
04/29/22 Oppenheimer
Roku price target lowered to $155 from $185 at Oppenheimer
FBHS Fortune Brands
$73.69 /

-2.41 (-3.17%)

04/29/22 Truist
Fortune Brands price target lowered to $100 from $115 at Truist
04/29/22 BofA
Fortune Brands upgraded to Neutral at BofA on cabinets spinoff plan
04/29/22 BofA
Fortune Brands upgraded to Neutral from Underperform at BofA
04/29/22 KeyBanc
Fortune Brands downgraded to Sector Weight from Overweight at KeyBanc
BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

04/18/22 Goldman Sachs
Nektar downgraded to Sell from Neutral at Goldman Sachs
04/18/22 Mizuho
Nektar price target lowered to $6 from $8 at Mizuho
04/06/22 Morgan Stanley
Bristol-Myers assumed with an Underweight at Morgan Stanley
03/30/22 BMO Capital
Bristol-Myers price target raised to $81 from $74 at BMO Capital
ZYME Zymeworks
$6.67 /

+1.7 (+34.21%)

WU Western Union
$17.04 /

-2.12 (-11.06%)

WIT Wipro
$6.50 /

-0.305 (-4.48%)

WB Weibo
$23.63 /

+2.375 (+11.17%)

TWTR Twitter
$49.55 /

+0.37 (+0.75%)

TSLA Tesla
$905.80 /

+28.79 (+3.28%)

TAL TAL Education
$3.40 /

+0.38 (+12.58%)

ROKU Roku
$98.10 /

+6.6 (+7.21%)

RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

OLN Olin
$57.93 /

+4.64 (+8.71%)

NFLX Netflix
$197.76 /

-1.73 (-0.87%)

MHK Mohawk Industries
$142.67 /

+11.86 (+9.07%)

MA MasterCard
$368.80 /

-9.82 (-2.59%)

LIAN LianBio
$3.90 /

-1.12 (-22.31%)

JD JD.com
$62.81 /

+5.03 (+8.71%)

INTC Intel
$44.13 /

-2.845 (-6.06%)

HSBC HSBC
$31.30 /

+0.3 (+0.97%)

HON Honeywell
$194.93 /

+4.87 (+2.56%)

FBHS Fortune Brands
$73.69 /

-2.41 (-3.17%)

EGO Eldorado Gold
$9.70 /

-0.845 (-8.01%)

CVX Chevron
$158.10 /

-3.8 (-2.35%)

CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

CLW Clearwater Paper
$33.84 /

+6.08 (+21.90%)

CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

BABA Alibaba
$100.62 /

+9.78 (+10.77%)

AVTR Avantor
$32.32 /

+2.47 (+8.27%)

AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

ACCD Accolade
$5.96 /

-5.1 (-46.11%)

ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

  • 27
    Jan
  • 02
    Dec
  • 10
    Nov
  • 10
    Nov
  • 01
    Nov
  • 14
    Sep
  • 19
    May
WB Weibo
$23.63 /

+2.375 (+11.17%)

TWTR Twitter
$49.55 /

+0.37 (+0.75%)

TSLA Tesla
$905.80 /

+28.79 (+3.28%)

ROKU Roku
$98.10 /

+6.6 (+7.21%)

RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

NFLX Netflix
$197.76 /

-1.73 (-0.87%)

MA MasterCard
$368.80 /

-9.82 (-2.59%)

INTC Intel
$44.13 /

-2.845 (-6.06%)

HSBC HSBC
$31.30 /

+0.3 (+0.97%)

HNHPF Hon Hai Precision
$6.84 /

+0.175 (+2.63%)

CVX Chevron
$158.10 /

-3.8 (-2.35%)

CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

BABA Alibaba
$100.62 /

+9.78 (+10.77%)

AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

WU Western Union
$17.04 /

-2.12 (-11.06%)

WIT Wipro
$6.50 /

-0.305 (-4.48%)

WB Weibo
$23.63 /

+2.375 (+11.17%)

TWTR Twitter
$49.55 /

+0.37 (+0.75%)

TSLA Tesla
$905.80 /

+28.79 (+3.28%)

TAL TAL Education
$3.40 /

+0.38 (+12.58%)

ROKU Roku
$98.10 /

+6.6 (+7.21%)

RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

OLN Olin
$57.93 /

+4.64 (+8.71%)

NFLX Netflix
$197.76 /

-1.73 (-0.87%)

MHK Mohawk Industries
$142.67 /

+11.86 (+9.07%)

MA MasterCard
$368.80 /

-9.82 (-2.59%)

LIAN LianBio
$3.90 /

-1.12 (-22.31%)

JD JD.com
$62.81 /

+5.03 (+8.71%)

INTC Intel
$44.13 /

-2.845 (-6.06%)

HON Honeywell
$194.93 /

+4.87 (+2.56%)

HNHPF Hon Hai Precision
$6.84 /

+0.175 (+2.63%)

FBHS Fortune Brands
$73.69 /

-2.41 (-3.17%)

CVX Chevron
$158.10 /

-3.8 (-2.35%)

CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

CLW Clearwater Paper
$33.84 /

+6.08 (+21.90%)

CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

BABA Alibaba
$100.62 /

+9.78 (+10.77%)

AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

ACCD Accolade
$5.96 /

-5.1 (-46.11%)

ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

WU Western Union
$17.04 /

-2.12 (-11.06%)

WB Weibo
$23.63 /

+2.375 (+11.17%)

TWTR Twitter
$49.55 /

+0.37 (+0.75%)

TSLA Tesla
$905.80 /

+28.79 (+3.28%)

TAL TAL Education
$3.40 /

+0.38 (+12.58%)

ROKU Roku
$98.10 /

+6.6 (+7.21%)

RIVN Rivian Automotive
$31.75 /

-0.45 (-1.40%)

PDD Pinduoduo
$44.40 /

+6.45 (+17.00%)

OLN Olin
$57.93 /

+4.64 (+8.71%)

NFLX Netflix
$197.76 /

-1.73 (-0.87%)

MHK Mohawk Industries
$142.67 /

+11.86 (+9.07%)

MA MasterCard
$368.80 /

-9.82 (-2.59%)

JD JD.com
$62.81 /

+5.03 (+8.71%)

INTC Intel
$44.13 /

-2.845 (-6.06%)

HSBC HSBC
$31.30 /

+0.3 (+0.97%)

HON Honeywell
$194.93 /

+4.87 (+2.56%)

CVX Chevron
$158.10 /

-3.8 (-2.35%)

CMCSA Comcast
$40.02 /

-1.695 (-4.06%)

CG Carlyle Group
$37.74 /

-0.74 (-1.92%)

BMY Bristol-Myers
$74.80 /

-2.385 (-3.09%)

BABA Alibaba
$100.62 /

+9.78 (+10.77%)

AMZN Amazon.com
$2,520.02 /

-366.49 (-12.70%)

ACCD Accolade
$5.96 /

-5.1 (-46.11%)

ABBV AbbVie
$142.37 /

-14.02 (-8.96%)

AAPL Apple
$160.53 /

-3.26 (-1.99%)

Hot Stocks
LianBio announces FDA approved Camzyos » 08:21
04/29/22
04/29
08:21
04/29/22
08:21
LIAN

LianBio

$5.02 /

-0.02 (-0.40%)

, BMY

Bristol-Myers

$77.20 /

+1.395 (+1.84%)

LianBio's (LIAN)…

LianBio's (LIAN) partner, Bristol Myers Squibb (BMY), announced yesterday that the U.S. Food and Drug Administration, FDA, approved Camzyos for the treatment of adults with symptomatic New York Heart Association, NYHA, class II-III obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms. LianBio licensed rights from MyoKardia, now a wholly owned subsidiary of Bristol Myers Squibb, in August 2020 for the development and commercialization of Camzyos in Mainland China, Hong Kong, Macau, Taiwan, Thailand and Singapore. LianBio is currently conducting EXPLORER-CN, a Phase 3 multicenter, double-blind, randomized, placebo-controlled registrational study designed to evaluate the safety and efficacy of mavacamten in Chinese patients with symptomatic obstructive HCM. Camzyos was granted Breakthrough Therapy Designation in China for the treatment of patients with obstructive HCM. "We congratulate Bristol Myers Squibb on receiving U.S. FDA approval for Camzyos in patients with symptomatic NYHA class II-III obstructive HCM," said Yizhe Wang, Ph.D., chief executive officer of LianBio. "Obstructive HCM is a debilitating heart disease with significant unmet medical need in China. We estimate there are approximately 1.1 million to 2.8 million patients with HCM in China, and approximately two-thirds of those patients have symptomatic obstructive HCM. We are excited to continue our strategic collaboration and further development of Camzyos in China and other Asian markets to help bring this promising treatment to patients in need."

ShowHide Related Items >><<
LIAN LianBio
$5.02 /

-0.02 (-0.40%)

BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

LIAN LianBio
$5.02 /

-0.02 (-0.40%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

04/18/22 Goldman Sachs
Nektar downgraded to Sell from Neutral at Goldman Sachs
04/18/22 Mizuho
Nektar price target lowered to $6 from $8 at Mizuho
04/06/22 Morgan Stanley
Bristol-Myers assumed with an Underweight at Morgan Stanley
03/30/22 BMO Capital
Bristol-Myers price target raised to $81 from $74 at BMO Capital
LIAN LianBio
$5.02 /

-0.02 (-0.40%)

BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

  • 01
    Nov
BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

LIAN LianBio
$5.02 /

-0.02 (-0.40%)

BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

BMY Bristol-Myers
$77.20 /

+1.395 (+1.84%)

Hot Stocks
MeiraGTx appoints Debra Yu to board of directors » 08:03
04/27/22
04/27
08:03
04/27/22
08:03
MGTX

MeiraGTx

$11.79 /

-1.06 (-8.25%)

, LIAN

LianBio

$4.67 /

-0.095 (-2.00%)

MeiraGTx Holdings (MGTX)…

MeiraGTx Holdings (MGTX) announced the appointment of Dr. Debra Yu to its Board of Directors. Dr. Yu currently serves as President and Chief Strategy Officer of LianBio (LIAN), and previously served as LianBio's President and Chief Business Officer.

ShowHide Related Items >><<
MGTX MeiraGTx
$11.79 /

-1.06 (-8.25%)

LIAN LianBio
$4.67 /

-0.095 (-2.00%)

MGTX MeiraGTx
$11.79 /

-1.06 (-8.25%)

03/10/22 Piper Sandler
MeiraGTx pipeline tracking to expectations, says Piper Sandler
12/07/21 Piper Sandler
MeiraGTx update 'about as good as hoped,' says Piper Sandler
08/11/21 Piper Sandler
Piper remains buyer of MeiraGTx 'into $40 range' after 'quiet' Q2
07/09/21 Chardan
MeiraGTx coverage transferred at Chardan
LIAN LianBio
$4.67 /

-0.095 (-2.00%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
MGTX MeiraGTx
$11.79 /

-1.06 (-8.25%)

LIAN LianBio
$4.67 /

-0.095 (-2.00%)

  • 01
    Nov
LIAN LianBio
$4.67 /

-0.095 (-2.00%)

Over a month ago
Hot Stocks
LianBio partner ReViral expected to be acquired by Pfizer » 19:10
04/07/22
04/07
19:10
04/07/22
19:10
LIAN

LianBio

$5.39 /

+0.46 (+9.33%)

, PFE

Pfizer

$55.16 /

+2.29 (+4.33%)

LianBio (LIAN) announced…

LianBio (LIAN) announced that its partner, ReViral, is expected to be acquired by Pfizer Inc. (PFE). LianBio has existing collaboration agreements with both companies, including an in-licensing agreement with ReViral for the development of sisunatovir, a small-molecule antiviral for the treatment of respiratory syncytial virus. "We are pleased that Pfizer has seen the same promise in ReViral and their RSV pipeline as we do," said Yizhe Wang, Ph.D., Chief Executive Officer of LianBio. "We are looking forward to expanding our existing relationship with Pfizer and continuing our mission to bring novel therapeutics, including sisunatovir, to greater China." LianBio and Pfizer entered into a strategic collaboration agreement in November 2020 focused on developing and commercializing transformative pharmaceutical products in greater China. In March 2021, LianBio and ReViral announced an exclusive collaboration and license agreement for the development and commercialization of sisunatovir in mainland China, Hong Kong, Macau, and Singapore.

ShowHide Related Items >><<
PFE Pfizer
$55.16 /

+2.29 (+4.33%)

LIAN LianBio
$5.39 /

+0.46 (+9.33%)

LIAN LianBio
$5.39 /

+0.46 (+9.33%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
PFE Pfizer
$55.16 /

+2.29 (+4.33%)

04/06/22 Morgan Stanley
Pfizer assumed with an Equal Weight at Morgan Stanley
04/05/22 Citi
Citi ups Pfizer target, opens 'positive Catalyst Watch'
03/28/22 KeyBanc
Codex DNA price target lowered to $8 from $30 at KeyBanc
02/15/22
FDA Vaccines and Related Biological Products Advisory Committee to hold meeting
PFE Pfizer
$55.16 /

+2.29 (+4.33%)

LIAN LianBio
$5.39 /

+0.46 (+9.33%)

  • 01
    Nov
PFE Pfizer
$55.16 /

+2.29 (+4.33%)

PFE Pfizer
$55.16 /

+2.29 (+4.33%)

LIAN LianBio
$5.39 /

+0.46 (+9.33%)

PFE Pfizer
$55.16 /

+2.29 (+4.33%)

Hot Stocks
LianBio appoints Chen to board of directors » 08:11
04/07/22
04/07
08:11
04/07/22
08:11
LIAN

LianBio

$4.93 /

-0.07 (-1.40%)

, SBUX

Starbucks

$83.37 /

-0.74 (-0.88%)

LianBio (LIAN) announced…

LianBio (LIAN) announced the appointment of Wei Wei Chen to the company's Board of Directors. Chen brings over 17 years of experience. Most recently, she served as Vice President, Chief Financial Officer of Starbucks (SBUX), China, Company Limited.

ShowHide Related Items >><<
SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

LIAN LianBio
$4.93 /

-0.07 (-1.40%)

LIAN LianBio
$4.93 /

-0.07 (-1.40%)

11/26/21 BofA
LianBio initiated with a Buy at BofA
11/26/21 Goldman Sachs
LianBio initiated with a Neutral at Goldman Sachs
11/26/21 Jefferies
LianBio initiated with a Buy at Jefferies
11/24/21 Raymond James
LianBio initiated with an Outperform at Raymond James
SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
04/05/22 BMO Capital
Starbucks price target lowered to $115 from $125 at BMO Capital
04/05/22 Wedbush
Starbucks downgraded to Neutral from Outperform at Wedbush
03/23/22 Jefferies
Starbucks' 'unwarranted' recent pullback a buying opportunity, says Jefferies
SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

LIAN LianBio
$4.93 /

-0.07 (-1.40%)

  • 01
    Nov
SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

LIAN LianBio
$4.93 /

-0.07 (-1.40%)

SBUX Starbucks
$83.37 /

-0.74 (-0.88%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.